Open Targets: a platform for therapeutic target identification and validation.

阅读:6
作者:Koscielny Gautier, An Peter, Carvalho-Silva Denise, Cham Jennifer A, Fumis Luca, Gasparyan Rippa, Hasan Samiul, Karamanis Nikiforos, Maguire Michael, Papa Eliseo, Pierleoni Andrea, Pignatelli Miguel, Platt Theo, Rowland Francis, Wankar Priyanka, Bento A Patrícia, Burdett Tony, Fabregat Antonio, Forbes Simon, Gaulton Anna, Gonzalez Cristina Yenyxe, Hermjakob Henning, Hersey Anne, Jupe Steven, Kafkas Şenay, Keays Maria, Leroy Catherine, Lopez Francisco-Javier, Magarinos Maria Paula, Malone James, McEntyre Johanna, Munoz-Pomer Fuentes Alfonso, O'Donovan Claire, Papatheodorou Irene, Parkinson Helen, Palka Barbara, Paschall Justin, Petryszak Robert, Pratanwanich Naruemon, Sarntivijal Sirarat, Saunders Gary, Sidiropoulos Konstantinos, Smith Thomas, Sondka Zbyslaw, Stegle Oliver, Tang Y Amy, Turner Edward, Vaughan Brendan, Vrousgou Olga, Watkins Xavier, Martin Maria-Jesus, Sanseau Philippe, Vamathevan Jessica, Birney Ewan, Barrett Jeffrey, Dunham Ian
We have designed and developed a data integration and visualization platform that provides evidence about the association of known and potential drug targets with diseases. The platform is designed to support identification and prioritization of biological targets for follow-up. Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources. The platform provides either a target-centric workflow to identify diseases that may be associated with a specific target, or a disease-centric workflow to identify targets that may be associated with a specific disease. Users can easily transition between these target- and disease-centric workflows. The Open Targets Validation Platform is accessible at https://www.targetvalidation.org.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。